547

• adjuvant therapies
• anticoagulant
• anticoagulant, curative dose
• anticoagulant, prophylactic dose
• Bivalirudin
• heparin at therapeutic dose
• sulodexide
• colchicine
• face mask
• febuxostat
• hydrogen-oxygen nebulizer
• hyperbaric oxygen
• nintedanib
• pulmonary rehabilitation
• thalidomide
• vitamin C
• anti-inflammatoty and immuno-therapy
• A EFFACER anticorps
• acalabrutinib
• anti-inflammatory therapies
• IFX-1
• mepolizumab
• naproxen, ibuprofen
• non-steroidal anti-inflammatory drugs
• Celecoxib
• Ibuprofen
• Indomethacin
• sodium aescinate
• Apilimod
• corticosteroids
• ciclesonide
• dexamethasone
• Hydrocortisone
• inhaled corticosteroids
• low-dose corticosteroids
• methylprednisolone
• imatinib
• Immunostimulants drugs
• anti-PD-1 antibody
• CD24Fc
• convalescent plasma treatment
• immunoglobulin therapy
• emapalumab
• inactivated mycobacterium vaccine
• interferon
• IFN beta-1a
• IFN beta-1b
• interferon / TFF2
• peginterferon
• SNG001 inhaled interferon beta
• Interleukin-2
• neutralizing antibody
• bamlanivimab monotherapy
• bamlanivimab plus etesevimab
• casirivimab and imdevimab (REGN-COV2)
• VIR-7831 / GSK4182136
• rhG-CSF
• Vitamin D
• Immunosuppressants drugs
• adalimumab
• anakinra
• anti-interleukin-6
• clazakizumab
• sarilumab
• sarilumab azithromycin hydroxychloroquine
• sarilumab high dose (400mg)
• sarilumab low dose (200mg)
• siltuximab
• tocilizumab
• baricitinib
• baricitinib plus remdesivir
• eculizumab
• jakotinib
• lenzilumab
• ruxolitinib
• tacrolimus
• tetrandrine
• leflunomide
• pirfenidone
• Polyinosinic-Polycytidylic Acid
• sargramostim
• thymosin
• antiandrogenic
• 5-alpha-reductase inhibitors
• antiviral and associated therapy
• ASC09/ritonavir
• azithromycin
• azvudine
• baloxavir marboxil
• carrimycin
• chloroquine and derivatives
• chloroquine
• hydroxychloroquine
• danoprevir / ritonavir
• darunavir cobicistat
• darunavir/cobicistat plus chloroquine
• doxycycline
• favipiravir
• fluvoxamine
• hydroxychloroquine plus macrolides
• ivermectin
• leronlimab
• lopinavir / ritonavir plus ribavirin
• lopinavir/ritonavir
• lopinavir/ritonavir plus chloroquine
• lopinavir/ritonavir plus interferon ß-1a
• lopinavir/ritonavir, ribavirin and interferon beta-1b
• meplazumab
• nitazoxanide
• oseltamivir
• oseltamivir plus chloroquin
• remdesivir
• Renin-angiotensin-system-acting agents
• angiotensin converting enzyme inhibitors (ACEIs)
• angiotensin receptor blockers (ARBs)
• angiotensin-(1-7)
• discontinuation of ACEI/ARB
• RAS blocker withdrawal
• rhACE2
• ribavirin
• ritonavir
• sofosbuvir and daclatasvir
• tenofovir/emtricitabine
• tenofovir/emtricitabine plus hydroxychloroquine
• tranexamic acid
• triazavirin
• umifenovir (arbidol)
• control
• placebo
• prone positioning
• standard of care
• honey
• miscellaneous
• acetylcysteine
• alpha lipoic acid
• aviptadil
• bevacizumab
• bismuth
• BLD-2660 (calpain inhibitor)
• calcium channel blocker
• camostat mesilate
• continuous positive airway pressure (CPAP)
• cytokine adsorption
• diammonium glycyrrhizinate
• dipyridamol
• DPP-4 inhibitor
• enoxaparin
• famotidine
• kinin-kallikrein inhibitors
• levamisole
• metformin
• natural killer (NK) cells
• nicotin
• nitric oxide (gas Inhalation or releasing solution)
• ozonated autohemotherapy
• pamrevlumab
• povidone-iodine
• proton pump inhibitors (PPI)
• proxalutamide
• PUL-042 inhalation solution
• radiotherapy
• selinexor
• statins
• tradipitant
• tranilast
• zinc
• zinc plus hydroxychloroquine
• vaccines
• Ad.26.COV2.S (JNJ-78436725)
• BBV152 (Bharat Biotech, India)
• BCG vaccination
• CureVac
• DNA vaccine
• bacTRL-Spike
• Inactivated virus vaccine
• CoronaVac (SinoVac)
• Covaxin, Bharat Biotech, Indian Council of Medical Research
• Sinopharm Beijing (BBIBP-CorV)
• Sinopharm Wuhan
• Non replicating viral vector
• CanSino
• ChAdOx1 nCoV-19 (AstraZeneca Oxford)
• JNJ-78436735 AD26 (Janssen)
• Sputnik V (Gam-COVID-Vac)
• protein subunit vaccine
• Anhui Zhifei Longcom
• NVX-CoV2373 (Novavax)
• RNA vaccine
• Moderna COVID-19 vaccine
• tozinameran (Pfizer/BIONTECH)
• Sanofi/GSK recombinant protein vaccine
• SCB-2019
• virus-like particles vaccine
• Medicago
• Zy-Cov-D (Zydus Cadila)
• stem cells

• vs. potential COVID-19 treatments
• vs. adjuvant therapies
• vs. anticoagulant
• vs. anticoagulant, curative dose
• vs. antiviral and associated therapy
• vs. chloroquine and derivatives
• vs. hydroxychloroquine
• vs. control
• vs. placebo
• vs. standard of care

• All
• COVID-19
• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 prophylaxis
• infections other than COVID-19
• preventing respiratory virus transmission